ASH First Look: CAR-T Therapies Against BCMA, CD19 And More

 
• By Mandy Jackson
  
Binocular viewer_1200X675
BCMA CAR-T still is a hot topic, but novel therapies advance at ASH.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D